Clinical trials
Enrolling by invitation Neoplasm Metastasis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
5 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Enrolling by invitation | 5 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Casa Sollievo della Sofferenza IRCCS | 1 |
| Fundación Pública Andaluza para la Investigación Biomédica Andalucía Oriental | 1 |
| National Cancer Institute (NCI) | 1 |
| Ryvu Therapeutics SA | 1 |
| Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neoplasm Metastasis | 5 |
| Carcinoma, Non-Small-Cell Lung | 2 |
| Recurrence | 2 |
| Breast Neoplasms | 1 |
| Colorectal Neoplasms | 1 |
| Gastrointestinal Neoplasms | 1 |
| Leukemia, Myeloid, Acute | 1 |
| Melanoma | 1 |
| Myelodysplastic Syndromes | 1 |
| Neoplasms | 1 |
Trials
Showing 76 to 5 of 5. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.